CLSI NBS08

Newborn Screening for Hemoglobinopathies, 1st Edition, NBS08Ed1E

Clinical and Laboratory Standards Institute, 10/28/2019

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:28/10/2019

Pages:130

File Size:1 file , 8.1 MB

Note:This product is unavailable in Russia, Belarus

This guideline describes the recommended protocols for detecting hemoglobinopathies and thalassemias by population-based newborn screening using dried blood spot specimens. Early, presymptomatic detection to identify newborns with abnormal hemoglobins is critical because it improves treatment effectiveness.

More CLSI standard pdf

CLSI EP07-A2

CLSI EP07-A2

Interference Testing in Clinical Chemistry; Approved Guideline, EP07A2E

$147.00 $294.47

CLSI MM14-A

CLSI MM14-A

Proficiency Testing (External Quality Assessment) for Molecular Methods; Approved Guideline, MM14A

$103.00 $207.91

CLSI H45A2

CLSI H45A2

Performance of the Bleeding Time Test; Approved Guideline, H45-A2

$90.00 $180.00

CLSI M28-A2

CLSI M28-A2

Procedures for the Recovery and Identification of Parasites From the Intestinal Tract; Approved Guideline, M28A2E

$90.00 $180.00